Hereβs the detailed profile for Gentamicin Injection 40 mg/mL π
π Gentamicin Injection 40 mg/mL
π Description:
- Gentamicin is a potent aminoglycoside antibiotic.
- Supplied as solution for injection (40 mg/mL) in ampoules/vials.
- Mechanism of action: Binds to the 30S ribosomal subunit, interfering with protein synthesis and causing misreading of mRNA β bactericidal effect.
- Effective against aerobic Gram-negative bacilli and some Gram-positive bacteria (in combination therapy).
π Prescription / Indications:
Used in serious bacterial infections, including:
- Septicemia and bacteremia
- Severe respiratory tract infections (hospital-acquired pneumonia)
- Urinary tract infections (complicated, resistant cases)
- Intra-abdominal infections (often with metronidazole/Ξ²-lactams)
- Meningitis (neonatal/infant) β in combination therapy
- Endocarditis (with ampicillin, penicillin, or vancomycin for synergy)
- Skin, bone, and soft tissue infections
- Prophylaxis in surgical procedures (selected cases)
πΏ Nature / Drug Class:
- Antibiotic β Aminoglycoside
- Concentration-dependent bactericidal activity
- Has a post-antibiotic effect against Gram-negative organisms
β Advantages:
- Highly effective in life-threatening Gram-negative infections
- Synergistic with Ξ²-lactams or glycopeptides against Gram-positive organisms (esp. enterococci)
- Useful for neonatal sepsis and nosocomial infections
- The 40 mg/mL strength is commonly used in adults and hospital settings (more practical for dosing than 10 mg/mL)
β οΈ Precautions:
Contraindications:
- Allergy to aminoglycosides
Cautions:
- Narrow therapeutic window β requires careful dosing and monitoring
- Renal impairment β dose adjustment mandatory
- Avoid long-term use (β toxicity risk)
- Avoid with other nephrotoxic/ototoxic drugs (vancomycin, amphotericin B, cisplatin, loop diuretics)
Adverse Effects:
- Nephrotoxicity (reversible if detected early)
- Ototoxicity β auditory & vestibular damage (may be irreversible)
- Neuromuscular blockade (rare; worsens myasthenia gravis)
- Local pain/irritation at injection site
π¦ Common Packaging:
- Ampoules/vials containing 2 mL or 10 mL solution (40 mg/mL concentration)
- Hospital packs also available
π Administration:
- Intramuscular (IM) injection
- Intravenous (IV) slow injection or infusion (over 30β60 minutes)
- Dosage based on:
- Body weight (mg/kg)
- Infection severity
- Renal function
- Therapeutic drug monitoring (TDM) strongly recommended (peak & trough levels)
βοΈ Storage Conditions:
- Store at 15β25Β°C
- Protect from light
- Do not freeze

